PetMed Express (PETS) vs 111 (YI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
111 (YI) has outperformed PetMed Express (PETS) over the past year, losing 35.5% versus a loss of 47.2%. Over five years, YI leads with a -42.7% price change compared with -97.1% for PETS. 111 is the larger company by market cap ($20.8 million vs $18.9 million), about 1.1 times the size.
111 converts more of its revenue into profit, with a net margin of -0.2% versus -32.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PETS | YI |
|---|---|---|
| Share price | $0.8501 | $2.36 |
| Market cap | $18.90M | $20.76M |
| 1-day change | -8.04% | -5.98% |
| YTD return | -73.43% | -7.81% |
| 1-year return | -47.20% | -35.52% |
| 5-year return | -97.07% | -42.72% |
| P/E ratio (TTM) | — | 0.23 |
| Forward P/E | — | 16.86 |
| EPS (TTM) | $-1.29 | $10.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $179.02M | $1.80B |
| Revenue growth (YoY) | -21.13% | -9.00% |
| Net income (latest FY) | $-57.29M | $-3.22M |
| Gross margin | 28.05% | 5.76% |
| Operating margin | -32.77% | -0.02% |
| Net margin | -32.00% | -0.18% |
| 52-week high | $4.10 | $11.17 |
| 52-week low | $0.8466 | $2.34 |
| Distance from 52-week high | -79.27% | -78.87% |
| Analyst consensus | sell | — |
| Avg. price target upside | +64.69% | — |
| Average volume | 118.20K | 15.93K |
| Shares outstanding | 22.23M | 5.20M |
| Employees | 189 | 1,063 |
| Sector | Consumer Staples | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores | Retail-Drug Stores and Proprietary Stores |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- YI has outperformed PETS by 11.7 percentage points over the past year.
- 111 is more profitable, keeping -0.2 cents of every revenue dollar as net income versus -32.0 cents for PetMed Express.
- 111 grew revenue faster in its latest fiscal year (-9.00% vs -21.13%).
About PetMed Express
PETS stock →PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 189 employees
About 111
YI stock →111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 1,063 employees
PETS vs YI FAQ
Which is bigger, PetMed Express or 111?
111 (YI) is larger, with a market capitalization of $20.76M compared with $18.90M for PetMed Express (PETS).
Which stock has performed better over the past year, PETS or YI?
YI returned -35.52% over the past 12 months, compared with -47.20% for PETS (price return, excluding dividends). Past performance does not predict future results.
Are PetMed Express and 111 in the same industry?
Yes. Both are classified in the Retail-Drug Stores and Proprietary Stores industry within the Consumer Staples sector.